Registration - In-house Corporation

Subject Matters

• Consumer Issues
• Government Procurement
• Health
• Industry
• Intellectual Property
• International Relations
• International Trade
• Regional Development
• Research and Development
• Science and Technology
• Taxation and Finance

Subject Matter Details

Grant, Contribution or Other Financial Benefit

• National Immunization Strategy. Advocacy to seek continued funding in vaccines.

Legislative Proposal, Bill or Resolution, Policies or Program, Regulation

• Consider amendments to the Food and Drugs Act, or the Export and Imports Permits Act (Export Control List) or any other legislative and regulatory means in order to protect the Canadian supply of drugs in light of potential importation legislation in the United States.
• Monitoring and engaging on the Act to implement the Agreement between Canada, the United States of America and the United Mexican States and related changes or implementation of regulations and guidelines, Formerly known as Bill C-4 "An Act to implement the Agreement between Canada, the United States of America and the United Mexican States". .

Legislative Proposal, Bill or Resolution, Regulation

• Monitoring and engaging on the Act respecting certain measures in response to COVID-19 and the changes to the Patent Act, including eventual regulations and guidelines, formally known as Bill C-13, An Act respecting certain measures in response to COVID-19 .

Policies or Program

• Federal Public Drug Plans, with respect to the reimbursement of therapeutic products for Federal plan beneficiaries
• Health Canada’s policies, program and guidelines related to the management, prevention, mitigation and notification of drug shortages and discussion on COVID19 potential impacts
• The Department of Innovation, Science and Economic Development and its Innovation Agenda for the life sciences sector: policy or program initiatives to support life science Research and Development conducted in Canada

Policies or Program, Regulation

• Patented Medicine Prices Review Board (PMPRB) amendments to the Patented Medicines Regulations and the related proposed draft guidelines.
• Regulations, policies and programs related to the reimbursement recommendations decision-making process and framework done by the Canadian Agency for Drugs and Technologies in Health (CADTH)/Common Drug Review as well as the review times and processes conducted by Health Canada for the purpuse of obtaining a notice of compliance.
• Subsequent Entry Biologics (SEBs) and Orphan Drugs framework: seeking an approval framework supported and protected by Regulations in harmonization with other developed countries

Communication Techniques

• Written communication
• Oral communication
• Grass-roots communication

Government Institutions

• Atlantic Canada Opportunities Agency (ACOA)
• Canada Economic Development for Quebec Regions
• Canada Revenue Agency (CRA)
• Canadian Institutes of Health Research (CIHR)
• Employment and Social Development Canada (ESDC)
• Finance Canada (FIN)
• Global Affairs Canada (GAC)
• Health Canada (HC)
• House of Commons
• Indigenous Services Canada (ISC)
• Innovation, Science and Economic Development Canada (ISED)
• Justice Canada (JC)
• National Defence (DND)
• Patented Medicine Prices Review Board (PMPRB)
• Prime Minister's Office (PMO)
• Privy Council Office (PCO)
• Public Health Agency of Canada (PHAC)
• Public Services and Procurement Canada (PSPC)
• Senate of Canada
• Treasury Board Of Canada Secretariat (TBS)
• Veterans Affairs Canada (VAC)
• Western Economic Diversification Canada (WD)

Address:
17,300 TRANS-CANADA HIGHWAY
KIRKLAND, QC  H9J 2M5
Canada

Telephone number: 514-693-4264

Parent Company Information